A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma

被引:0
|
作者
Mary Lou Keohan
Michael R. Grever
Stanley P. Balcerzak
Karen Antman
机构
[1] Columbia University,
[2] Johns Hopkins University,undefined
[3] Ohio State University Health Center,undefined
来源
Investigational New Drugs | 1997年 / 15卷
关键词
soft tissue sarcoma; chemotherapy; cisplatin; vinblastine;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose and Methods: Bone and soft tissue sarcomas currently comprise 1% of adult malignancies and 15% of pediatric malignancies [1]. While doxorubicin and ifosfamide are active agents, no significant impact on survival has been observed. More active regimes are required in sarcoma. This trial studied cisplatin and a 5 day continuous infusion of vinblastine for patients who had had disease progression of advanced soft tissue sarcoma after a doxorubicin based regimen.
引用
收藏
页码:255 / 256
页数:1
相关论文
共 50 条
  • [1] A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma
    Keohan, ML
    Grever, MR
    Balcerzak, SP
    Antman, K
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (03) : 255 - 256
  • [2] Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group phase II study
    Saeter, G
    Alvegard, TA
    Monge, OR
    Strander, H
    Turesson, I
    Klepp, R
    Soderberg, M
    Wist, E
    Raabe, N
    Erlanson, M
    Solheim, OP
    Hannisdal, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) : 1551 - 1558
  • [3] PHASE-II STUDY OF DIAZIQUONE IN ADVANCED SOFT-TISSUE AND BONY SARCOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    ZIDAR, BL
    BAKER, LH
    RIVKIN, SE
    BALCERZAK, SP
    STEPHENS, RL
    CANCER TREATMENT REPORTS, 1985, 69 (09): : 1035 - 1036
  • [4] A PHASE-II TRIAL OF CONTINUOUS INFUSION VINBLASTINE IN PATIENTS WITH GASTRIC-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    VONHOFF, DD
    GOODMAN, PJ
    PRESANT, CA
    RUXER, RL
    MACDONALD, JS
    COSTANZI, JJ
    STEPHENS, RL
    VOGEL, SJ
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (03) : 405 - 407
  • [5] PHASE-II TRIAL OF MERBARONE IN SOFT-TISSUE SARCOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    KRAUT, EH
    BENDETTI, J
    BALCERZAK, SP
    DOROSHOW, JH
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (04) : 347 - 349
  • [6] PHASE-II EVALUATION OF AMONAFIDE IN ADVANCED SARCOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUYS, SS
    METCH, B
    BALCERZAK, SP
    NEEFE, JR
    STUCKEY, WJ
    CANCER INVESTIGATION, 1994, 12 (04) : 399 - 402
  • [7] Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: A Southwest Oncology Group Study
    Margolin, KA
    Liu, PY
    Flaherty, LE
    Sosman, JA
    Walker, MJ
    Smith, JW
    Fletcher, WS
    Weiss, GR
    Unger, JM
    Sondak, VK
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 664 - 669
  • [8] PHASE-II TRIAL OF ECHINOMYCIN IN ADVANCED SOFT-TISSUE SARCOMAS - A SOUTHWEST ONCOLOGY GROUP-STUDY
    TAYLOR, SA
    METCH, B
    BALCERZAK, SP
    HANSON, KH
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (04) : 381 - 383
  • [9] 5-DAY VINBLASTINE INFUSION FOR PANCREATIC ADENOCARCINOMA - A PHASE-II SOUTHWEST ONCOLOGY GROUP-STUDY
    GUY, JT
    FLEMING, T
    POLLOCK, TW
    RIVKIN, SE
    PUGH, RP
    SAIERS, H
    HYNES, HE
    BOYD, JF
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (02) : 205 - 206
  • [10] Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group
    Woll, PJ
    Judson, I
    Lee, SM
    Rodenhuis, S
    Nielsen, OS
    Buesa, JM
    Lorigan, PC
    Leyvraz, S
    Hermans, C
    van Glabbeke, M
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) : 410 - 412